All News

 
ARTICLE – “Biosimilars: PrimeVigilance your Partner of Choice for Efficient and Cost-Effective Safety Surveillance”

written by PrimeVigilance Global Head of Project Management and Strategic Partnerships

Published
29 September 2022.

Read more
 
NEWS – Latest Pharmacovigilance Webinar open for registration

We invite you to join our next free educational webinar titled “How to Have a Robust and Strong Pharmacovigilance System”.

Published
20 September 2022.

Read more
 
NEWS – Article by PrimeVigilance Safety Experts focused on Medication Errors Reported with Methotrexate

Written by Ivona Bahnik Bisevac, PV Director of Benefit-Risk Management, Bojana Milasinovic, Senior PV Physician, and Katarina Stamatovic, Medical Reviewer

Published
16 September 2022.

Read more
 
NEWS – Pharmacovigilance Inpections and Audits Navigation webinar series continues

We invite you to join our next free educational webinar titled “Pharmacovigilance Inspections and Audits Navigation: From the Perspective of Inspector and Auditor”.

Published
23 June 2022.

Read more
 
NEWS – New EU Clinical Trials Regulation Webinar

We invite you to join our next free educational webinar titled “Safety Perspective of the New EU Clinical Trials Regulation”.

Published
11 March 2022.

Read more
 
PRESS RELEASE – Ergomed acquires ADAMAS, a leading global regulatory compliance provider

PrimeVigilance, an Ergomed company, is delighted to share the exciting news about Ergomed plc’s latest investment to expand our service offering significantly.

Published
9 February 2022.

Read more

This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Privacy Settings saved!
Cookie Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

  • __cfduid

Decline all Services
Accept all Services